Results 71 to 79 of about 112 (79)

[Mucoregulators in acute bronchitis syndromes: focus on use by general practitioners and data from the literature].

Therapie, 2004
Antibiotics have long been used in the initial treatment of acute bronchitis (AB) and acute exacerbations of chronic bronchitis (AECB). However, their lack of value in AB has been clearly demonstrated and antibiotic therapy is justified in only a few cases of AECB.
Nicolas, Roche, Bernard, Lebeau, Jean-Claude, Pujet, Gérard, Lenoir, François, Liard, Karim, Keddad   +5 more
openaire   +1 more source

Mucoregulators in treatment of acute and chronic diseases of the nose and paranasal sinuses, non-suppurative diseases of the middle ear in children

Voprosy praktičeskoj pediatrii, 2016
T.I. Garashchenko, I.M. Kirichenko
openaire   +1 more source

The mucoregulator drug, talniflumate*, maintains existing lung function in patients with cystic fibrosis

Inpharma Weekly, 2003
openaire   +1 more source

Controlled clinical study on the activity of a new mucoregulating drug in obstructive bronchial pathology with a marked hypersecretory feature. The pediatric experience.

Minerva pediatrica, 1984
ROMANO C, GARGANI G. F, MINICUCCI, LAURA, NANTRON M, MINERVA P.E.D.I.A.T.R.I.C.A. . PMID   +4 more
openaire   +3 more sources

The importance of choosing a mucoregulator in the treatment of cough in case of upper and lower respiratory tract diseases. Experience of use and perspectives of carbocysteine therapy

Therapy
Poteshkina N.G. Poteshkina, Selivanova G.B. Selivanova   +1 more
openaire   +1 more source

[Mucolytics and mucoregulators].

Revue medicale de Bruxelles, 1987
openaire   +1 more source

Exclusive patent, know-how, process and technology crosslicense to research, develop, manufacture, have manufactured, import, export, market, use, sell, have sold and sublicense a pharmaceutical product in tablet and suspension forms containing Talniflumate, as an anti-inflammatory or as a mucoregulator to regulate or inhibit the synthesis or secretion of glycoproteins derived from the mucin genes from cells in the lung or other organs in the body of mammals.

2002
openaire   +1 more source

[Use of mucoregulating drugs in combined therapy of exudative otitis media].

Vestnik otorinolaringologii, 2003
openaire   +1 more source

(RS)-2-(2,3-dihydro-5-hydroxy-4,6,7-trimethylbenzofuranyl) acetic acids and 2-(2,3-dihydro-5-acyloxy-4,6,7-trimethylbenzofuranyl) acetic acids and esters thereof, useful as mucoregulator and anti-ischemic drugs

1991
BRUFANI MARIO, CECCARELLI STEFANO, GIANNETTI PATRIZIA, PAESANO AGNESE, SCURI ROMOLO, ZANARELLA SERGIO   +5 more
openaire   +1 more source